Press release
March 26, 2021
Oncology Investors to Hear “Cancer Device Company of the Year” Immunicom Present at MedInvest Conference
March 23, 2021
Breakthrough Immunotherapy Earns First Regulatory Approval for Triple Negative Breast Cancer (TNBC)
January 25, 2021
Immunicom Makes StartUpCity’s Global “Ten Most Promising 2020 Biotech Startups”
October 20, 2020
Immunicom CEO Amir Jafri Named a Top Healthcare Leader in CEO Today Healthcare Awards
July 9, 2020